Cardiovascular Health Research in the Workplace: A Workshop Report.

Heart disease and stroke are the first and fifth leading causes of death in the United States, respectively. Employers have a unique opportunity to promote cardiovascular health, because >60% of US adults are employed, and most spend half of their waking hours at work. Despite the scope of the opportunity, <1 in 5 businesses implement evidence-based, comprehensive workplace health programs, policies, and practices. Integrated, systems-based workplace health approaches that harness data science and technology may have the potential to reach more employees and be cost-effective for employers. To evaluate the role of the workplace in promoting cardiovascular health across the lifespan, the National Heart, Lung, and Blood Institute, the National Institute for Occupational Safety and Health, and the American Heart Association convened a workshop on March 7, 2019, to share best practices, and to discuss current evidence and knowledge gaps, practical application, and dissemination of the evidence, and the need for innovation in workplace health research and practice. This report presents the broad themes discussed at the workshop and considerations for promoting worker cardiovascular health, including opportunities for future research.

Revisiting Project Re-Engineered Discharge (RED): The Impact of a Pharmacist Telephone Intervention on Hospital Readmission Rates.

PURPOSE: Project Re-Engineered Discharge is a discharge nurse education (DNE) and pharmacist follow-up telephone intervention protocol that was shown to decrease rehospitalization significantly. The specific value of the pharmacist intervention was not originally evaluated. The objective of this study was to determine the impact of a pharmacist telephone intervention during the transition of care process on the rate of unplanned hospitalization within 30 days of patient discharge. METHODS: A retrospective chart review was completed for patients who received DNE counseling and were discharged to home from the family medicine service at Boston Medical Center from July 2012 to May 2013. Patients were stratified into two groups: contacted/intervention and unable to contact/no intervention. The primary outcome was the rate of unplanned hospital utilization including emergency department visits and readmissions within 30 days of discharge. Secondary end points included number of pharmacist interventions and time spent on phone calls. RESULTS: A total of 401 patients were identified; 277 patients received a pharmacist telephone intervention, and 124 patients were unable to be contacted. Baseline characteristics did not differ between the two groups, with the exception of a higher prevalence of substance abuse in the nonintervention group (41.9% vs 21.3%, p<0.001). The rate of unplanned hospitalization (visits/patient) was significantly reduced in the intervention group, compared with the unable-to-contact group (0.227 vs 0.519, p<0.001). Pharmacists made a total of 128 interventions and spent an average of 22 minutes on each telephone intervention. CONCLUSION: Patients unable to be contacted by a pharmacist after hospital discharge were more likely to be readmitted or visit the emergency department in the 30 days following discharge. A pharmacist telephone intervention as part of a comprehensive discharge protocol can have a positive impact on patients during the transition of care process by reducing incidence of unplanned hospital utilization.

Clinical impact of laboratory error on therapeutic drug monitoring of once-daily tobramycin in cystic fibrosis: Case series.

Once-daily dosing intravenous tobramycin is commonly used to treat cystic fibrosis pulmonary exacerbations. Clinicians often utilize historical therapeutic drug monitoring data to individualize the dose among patients who have been treated with tobramycin previously. This case series involves three patients with cystic fibrosis who had supra-therapeutic tobramycin levels despite use of a once-daily dosing that produced therapeutic drug levels during a previous hospital admission, raising questions about the validity of these levels. Investigation into several potential sources of error led to the discovery of an analyzer error in the laboratory. Once the laboratory's tobramycin analyzer was recalibrated, the reported levels were comparable to historical levels. This case series emphasizes the clinical importance of critically analyzing reported levels, and specifically, the importance of utilizing past therapeutic drug monitoring data, if available, for all patients treated with intravenous tobramycin. If a patient was therapeutic on a similar dose of tobramycin during a previous admission, a dose adjustment may not be necessary, and clinicians should consider repeating levels while pursuing alternative explanations for the discrepant serum levels.

Using innovative video doctor technology in primary care to deliver brief smoking and alcohol intervention.

Given physicians' increased responsibilities and time constraints, it is increasingly difficult for primary care physicians to assume a major role in delivering smoking and alcohol assessment and intervention. The authors developed an innovative use of computer technology in the form of a "video doctor" to support physicians with this. In this article, two brief interventions, delivered by an interactive, multimedia video doctor, that reduce primary care patients' smoking and alcohol use are detailed: (a) a patient-centered advice message and (b) a brief motivational intervention. The authors are testing the use of the video doctor to deliver these interventions in a randomized, controlled study, Project Choice. A pilot study testing the feasibility and acceptability of the video doctor suggests it was well received and accepted by patients (n = 52) and potentially provides an innovative, cost-effective, and practical way to support providers' efforts to reduce smoking and alcohol use in primary care populations.

Video study of physician selection: preferences in the face of diversity.

OBJECTIVES: To determine whether a diverse group of people would predominantly choose a white male physician regardless of group member's sex and ethnicity when given a choice among 6 actor-portrayed video doctors (males and females of Latino, European, and African descent) and whether further exposure would alter initial selections. STUDY DESIGN: Participants selected a video doctor after viewing a brief introduction and again after viewing the delivery of a prevention message. POPULATION: Three hundred ninety-five participants recruited at a shopping mall in the San Francisco Bay Area (61% female, 39% male; 30% Asian American, 29% European American, 26% Latino, 8% African American, and 7% other). OUTCOMES MEASURED: Initial and final video doctor selections; ratings of video doctors on interpersonal qualities. RESULTS: Most participants (85% of females and 63% of males) initially chose a female video doctor (P<.001) and even more did so at final selection. Approximately half initially chose a same-race video doctor (66% of European Americans, 51% of Latinos, and 50% of African Americans), but fewer did so at final selection (56% of European Americans, 44% of Latinos, and 52% of African Americans). In addition, at final selection 57% of Asian Americans and other-ethnicity participants chose a non-European American video doctor. CONCLUSIONS: Many healthcare consumers will accept physicians of both sexes and of different races. After observing the video doctors demonstrate a professional and warm affect, participants became even more receptive to choosing a video doctor of a different race. Video doctor technology holds promise for increasing our understanding of patients' preferences.